• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed

    2/12/21 5:06:42 PM ET
    $JWS
    Business Services
    Finance
    Get the next $JWS alert in real time by email
    SC 13G 1 t40796656a.htm SCHEDULE 13G
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    (Amendment No. __)*
    JAWS Acquisition Corp.
    (Name of Issuer)
    Common Stock, $0.0001 par value
    (Title of Class of Securities)
    G50744104
    (CUSIP Number)
    December 31, 2020
    (Date of Event Which Requires Filing of this Statement)
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    ☐ Rule 13d-1(b)
    ☐ Rule 13d-1(c)
    ☒ Rule 13d-1(d)
    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


    CUSIP No. G50744104
     
    13G
    Page 2 of 8 Pages
    1
    NAME OF REPORTING PERSON
    Third Point LLC
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
    (a) ☐
    (b) ☐
    3
    SEC USE ONLY
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
    0
    6
    SHARED VOTING POWER
    1,984,192
    7
    SOLE DISPOSITIVE POWER
    0
    8
    SHARED DISPOSITIVE POWER
    1,984,192
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    1,984,192
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
    N/A
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
    2.88%
    12
    TYPE OF REPORTING PERSON
    OO


    CUSIP No. G50744104
     
    13G
    Page 3 of 8 Pages
     
    1
    NAME OF REPORTING PERSON
    Daniel S. Loeb
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
    (a) ☐
    (b) ☐
    3
    SEC USE ONLY
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    United States
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
    0
    6
    SHARED VOTING POWER
    1,984,192
    7
    SOLE DISPOSITIVE POWER
    0
    8
    SHARED DISPOSITIVE POWER
    1,984,192
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    1,984,192
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
    N/A
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
    2.88%
    12
    TYPE OF REPORTING PERSON
    IN

    Item 1(a): Name of Issuer:
    Jaws Acquisition Corp. (the "Issuer").
    Item 1(b): Address of Issuer's Principal Executive Offices:
    The Issuer's principal executive offices are located at 1601 Washington Avenue, Suite 800, Miami Beach, FL 33139.

    Item 2(a): Name of Person Filing:
     
    (i)
    Third Point LLC, a Delaware limited liability company (the “Management Company”), which serves as investment manager or adviser to a variety of hedge funds and managed accounts (all such funds and accounts, collectively, the “Funds”), with respect to shares of Common Stock (as defined in Item 2(d)) directly owned by the Funds; and
     
    (ii)
    Mr. Daniel S. Loeb (“Mr. Loeb”), who is the Chief Executive Officer of the Management Company and controls its business activities, with respect to shares of Common Stock indirectly beneficially owned by Mr. Loeb by virtue of such position.
       
    The Management Company and Mr. Loeb are hereinafter sometimes collectively referred to as the “Reporting Persons.” Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.

    Item 2(b): Address of Principal Business Office or, if None, Residence:
    The address of the principal business office of the Management Company and Mr. Loeb is 55 Hudson Yards, New York, New York 10001.
    Item 2(c): Citizenship:
    The Management Company is organized as a limited liability company under the laws of the State of Delaware. Mr. Loeb is a United States citizen.
    Item 2(d): Title of Class of Securities:
    Class A ordinary shares, $0.0001 par value ("Common Stock").
    Item 2(e): CUSIP Number:
    G50744104.
    Item 3:  If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:

     
    A.
    [ ]
    Broker or dealer registered under Section 15 of the Act,
     
    B.
    [ ]
    Bank as defined in Section 3(a)(6) of the Act,
     
    C.
    [ ]
    Insurance Company as defined in Section 3(a)(19) of the Act,
     
    D.
    [ ]
    Investment Company registered under Section 8 of the Investment Company Act of 1940,
     
    E.
    [ ]
    Investment Adviser in accordance with Rule 13d-1(b)(1)(ii)(E),
     
    F.
    [ ]
    Employee Benefit Plan or Endowment Fund in accordance with 13d-1 (b)(1)(ii)(F),
     
    G.
    [ ]
    Parent Holding Company or control person in accordance with Rule 13d-1(b)(1)(ii)(G),
     
    H.
    [ ]
    Savings Association as defined in Section 3(b) of the Federal Deposit Insurance Act,
     
    I.
    [ ]
    Church Plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940,
     
    J.
    [ ]
    Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
    Item 4: Ownership:

    A. Third Point LLC
    (a) Amount beneficially owned: 1,984,192 shares of Common Stock.
    (b) Percent of class: 2.88%. The percentages used herein and in the rest of this Schedule 13G are calculated based upon the 69,000,000 of the Issuer’s Common Stock outstanding as of November 10, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed on November 10, 2020. Except as described in the preceding sentence, all amounts reported in this Schedule 13G are as of the opening of the market on February 12, 2021.
    (c) Number of shares as to which such person has:
    (i)
    Sole power to vote or direct the vote: -0-
    (ii)
    Shared power to vote or direct the vote: 1,984,192
    (iii)
    Sole power to dispose or direct the disposition: -0-
    (iv)
    Shared power to dispose or direct the disposition: 1,984,192

    B. Daniel S. Loeb
    (a) Amount beneficially owned: 1,984,192 shares of Common Stock.
    (b) Percent of class: 2.88%. The percentages used herein and in the rest of this Schedule 13G are calculated based upon the 69,000,000 of the Issuer’s Common Stock outstanding as of November 10, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed on November 10, 2020. Except as described in the preceding sentence, all amounts reported in this Schedule 13G are as of the opening of the market on February 12, 2021.
    (c) Number of shares as to which such person has:
    (i)
    Sole power to vote or direct the vote: -0-
    (ii)
    Shared power to vote or direct the vote: 1,984,192
    (iii)
    Sole power to dispose or direct the disposition: -0-
    (iv)
    Shared power to dispose or direct the disposition: 1,984,192

    Item 5: Ownership of Five Percent or Less of a Class:
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following:
    Item 6: Ownership of More than Five Percent on Behalf of Another Person:
    Other than as set forth herein, no other person has the right to receive or the power to direct the receipt of dividends from, or proceeds from the sale of, the securities reported herein.
    Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:
    Not applicable.
    Item 8: Identification and Classification of Members of the Group:
    Not applicable.
    Item 9: Notice of Dissolution of Group:
    Not applicable.
    Item 10: Certification:
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
    [Signatures on following page]

    SIGNATURE
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
    Dated: February 12, 2021
     
    THIRD POINT LLC
         
     
    By: Daniel S. Loeb, Chief Executive Officer
         
     
    By:
    /s/ William Song
       
    Name: William Song
       
    Title: Attorney-in-Fact
         
     
    DANIEL S. LOEB
         
     
    By:
    /s/ William Song
       
    Name: William Song
       
    Title: Attorney-in-Fact
         
         

    EXHIBIT INDEX

    Exhibit 99.1:
    Joint Filing Agreement, dated February 12, 2021, by and between Third Point LLC and Daniel S. Loeb.
    Exhibit 99.2:
    Power of Attorney granted by Daniel S. Loeb in favor of James P. Gallagher, William Song and Joshua L. Targoff, dated February 9, 2011, was previously filed with the SEC on February 11, 2011 as Exhibit 99.2 to Schedule 13G filed by Third Point LLC and Daniel S. Loeb with respect to Citadel Broadcasting Corporation and is incorporated herein by reference.

    Get the next $JWS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $JWS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $JWS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cano Health Closes Business Combination with Jaws Acquisition Corp. and Will Begin Trading on the New York Stock Exchange

    MIAMI, June 3, 2021 /PRNewswire/ -- Cano Health, Inc. ("Cano Health," the "Company," "we," "our" or "us"), a leading value-based primary care provider for seniors and underserved communities, today announced it has completed its business combination with Jaws Acquisition Corp. ("Jaws") (NYSE: JWS). The business combination, which was approved by Jaws' stockholders at its special meeting held on June 2, 2021, will enable Cano Health to achieve its vision of becoming America's leader in primary care and accelerate the Company's growth. Beginning June 4, 2021, Cano Health's shares of Class A common stock will trade on the New York Stock Exchange ("NYSE") under the symbol "CANO." "This is an imp

    6/3/21 4:10:00 PM ET
    $JWS
    Business Services
    Finance

    Jaws Acquisition Corp. Announces Extraordinary General Meeting Teleconference Details

    MIAMI, May 24, 2021 /PRNewswire/ -- Jaws Acquisition Corp. ("Jaws") (NYSE:JWS), today announced that, due to the public health and safety concerns related to the coronavirus (COVID-19) pandemic and recommendations and orders from federal and New York authorities, it is strongly encouraging that shareholders attend the extraordinary general meeting of its shareholders, which will be held on June 2, 2021 at 9:00 a.m., New York City Time (the "General Meeting"), by teleconference rather than in person. The purpose of the General Meeting is to vote on certain proposals relating to the previously announced merger between Jaws and Cano Health, LLC ("Cano Health" or the "Company"), the related Busi

    5/24/21 8:00:00 AM ET
    $JWS
    Business Services
    Finance

    Jaws Acquisition Corp. Announces Effectiveness of Registration Statement and Sets Special Meeting Date for Proposed Business Combination with Cano Health

    MIAMI, May 10, 2021 /PRNewswire/ -- Jaws Acquisition Corp. (NYSE:JWS), a special purpose acquisition company ("Jaws"), announced today the effectiveness of its Registration Statement, in connection with its previously announced merger with Cano Health, LLC ("Cano Health"), on Form S-4, with the United States Securities and Exchange Commission (the "SEC"). Jaws also announced a special meeting of its shareholders (the "Special Meeting") to approve the proposed merger agreement with Cano Health for June 2, 2021 at 9:00 a.m., Eastern Time, unless postponed or adjourned to a later date or time. Jaws will distribute the definitive proxy statement and proxy card to its stockholders of record as of

    5/10/21 8:00:00 AM ET
    $JWS
    Business Services
    Finance

    $JWS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by Morales Angel L

    3 - Cano Health, Inc. (0001800682) (Issuer)

    6/23/21 3:06:35 PM ET
    $JWS
    Business Services
    Finance

    SEC Form 3 filed by TRUJILLO SOLOMON D

    3 - Cano Health, Inc. (0001800682) (Issuer)

    6/15/21 7:12:01 PM ET
    $JWS
    Business Services
    Finance

    SEC Form 3 filed by Gold Lewis

    3 - Cano Health, Inc. (0001800682) (Issuer)

    6/15/21 6:44:37 PM ET
    $JWS
    Business Services
    Finance

    $JWS
    SEC Filings

    View All

    SEC Form 8-K filed by Jaws Acquisition Corp.

    8-K - Cano Health, Inc. (0001800682) (Filer)

    7/6/21 6:42:14 AM ET
    $JWS
    Business Services
    Finance

    SEC Form S-1 filed by Jaws Acquisition Corp.

    S-1 - Cano Health, Inc. (0001800682) (Filer)

    6/25/21 5:28:55 PM ET
    $JWS
    Business Services
    Finance

    Jaws Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Cano Health, Inc. (0001800682) (Filer)

    6/14/21 6:30:29 AM ET
    $JWS
    Business Services
    Finance

    $JWS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Jaws Acquisition Corp.

    SC 13D - Cano Health, Inc. (0001800682) (Subject)

    6/14/21 5:21:02 PM ET
    $JWS
    Business Services
    Finance

    SEC Form SC 13G filed by Jaws Acquisition Corp.

    SC 13G - Jaws Acquisition Corp. (0001800682) (Subject)

    4/5/21 8:30:35 AM ET
    $JWS
    Business Services
    Finance

    SEC Form SC 13G/A filed

    SC 13G/A - Jaws Acquisition Corp. (0001800682) (Subject)

    2/16/21 3:06:07 PM ET
    $JWS
    Business Services
    Finance